LPL Financial
AQST icon

LPL Financial’s Aquestive Therapeutics AQST Stock Holding History

LPL Financial’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Buy
83,463
+250
+0.3% +$1.05K ﹤0.01% 5330
2026
Q1 		$345K Sell
83,213
-19,175
-19% -$77.8K ﹤0.01% 5089
2025
Q4 		$661K Buy
102,388
+12,500
+14% +$77.9K ﹤0.01% 4462
2025
Q3 		$502K Buy
89,888
+12,000
+15% +$51.9K ﹤0.01% 4622
2025
Q2 		$258K Buy
+77,888
New +$223K ﹤0.01% 4889
2024
Q3 		– Sell
-10,113
Closed -$26.3K – 5169
2024
Q2 		$26.3K Sell
10,113
-44,130
-81% -$147K ﹤0.01% 4913
2024
Q1 		$231K Buy
+54,243
New +$181K ﹤0.01% 4395

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

LPL Financial's AQST Position: Q2 2026 in Review

LPL Financial increased its Aquestive Therapeutics (AQST) stake by 0.3% in Q2 2026, buying an estimated $1.05K and bringing the position to 83,463 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #5330.

LPL Financial first reported a position in AQST in Q1 2024 and has held it in 7 quarters since. The position peaked at $661K in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • LPL Financial held 83,463 shares of Aquestive Therapeutics worth $347K as of Q2 2026.
  • LPL Financial bought 250 Aquestive Therapeutics shares in Q2 2026, an estimated $1.05K.
  • Aquestive Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5330 holding.
  • LPL Financial first reported a position in Aquestive Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • LPL Financial's Aquestive Therapeutics position peaked at $661K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.